International collaborative proficiency study of Human Papillomavirus type 16 serology.
Vaccine
; 30(2): 294-9, 2012 Jan 05.
Article
in En
| MEDLINE
| ID: mdl-22079074
We performed an international proficiency study of Human Papillomavirus (HPV) type 16 serology. A common methodology for serology based on virus-like particle (VLP) ELISA was used by 10 laboratories in 6 continents. The laboratories used the same VLP reference reagent, which was selected as the most stable, sensitive and specific VLP preparation out of VLPs donated from 5 different sources. A blinded proficiency panel consisting of 52 serum samples from women with PCR-verified HPV 16-infection, 11 control serum samples from virginal women and the WHO HPV 16 International Standard (IS) serum were distributed. The mean plus 3 standard deviations of the negative control serum samples was the most generally useful "cut-off" criterion for distinguishing positive and negative samples. Using sensitivity of at least 50% and a specificity of 100% as proficiency criteria, 6/10 laboratories were proficient. In conclusion, an international Standard Operating Procedure for HPV serology, an international reporting system in International Units (IU) and a common "cut-off" criterion have been evaluated in an international HPV serology proficiency study.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Virology
/
Virosomes
/
Papillomavirus Infections
/
Antigens, Viral
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Evaluation_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Vaccine
Year:
2012
Document type:
Article
Affiliation country:
Sweden
Country of publication:
Netherlands